# Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer

> **NCT05779943** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Emory University** · enrollment: 20 (actual)

## Conditions studied

- Prostate Adenocarcinoma
- Recurrent Prostate Carcinoma

## Interventions

- **DRUG:** Furosemide
- **OTHER:** F18-rhPSMA-7.3
- **PROCEDURE:** Positron Emission Tomography
- **PROCEDURE:** Computed Tomography

## Key facts

- **NCT ID:** NCT05779943
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-04-27
- **Primary completion:** 2024-03-15
- **Final completion:** 2028-07-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-10-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05779943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05779943, "Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05779943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*